Evaluation of Nano-Albumin Based Antibiotic Delivery for Treatment of Bacterial Infection in Experimental Animals

Dina Galal El Din Salem Youssef;

Abstract


Infectious diseases represent a great risk as more than half of the deaths happening worldwide. Brucellosis is one of the diseases that caused by Brucella species, a bacterial pathogen.
Despite the profound success achieved by the usage of antibiotics against infectious diseases, bacterial infections still conseder one the greatest challenges the in global healthcare. In the last few years, nanotechnology allows the development of new products that are used in human medicine; for quick and specific drug delivery into cells and tissues.
The present study was aimed at preparing and characterizeing the nano- albumin particles and evaluateing thier safety on living lymphocyte cell culture for their potential therapeutic as drug carrier to enhance the treatment of brucella infection in male Balb.c mice.
The study was divided in to three parts, the first part aimed to prepare the nano-albumin particles using the desolvation technique. Three techniques were used for characterization of the prepared particles; Transmission Electron Microscopy (TEM) was used to determine the particles shape and size; Zeta Sizer to estimate the zeta potential of the surface of the prepared nano particles and the size of this particles and finally by using X Ray Diffraction (XRD) technique to assess the chemical structure of the prepared nanoparticles. The second pa


Other data

Title Evaluation of Nano-Albumin Based Antibiotic Delivery for Treatment of Bacterial Infection in Experimental Animals
Other Titles تقييم الالبيومين النانومترى كحامل للمضاد الحيوى لعلاج العدوى البكتيرية فى حيوانات التجارب
Authors Dina Galal El Din Salem Youssef
Issue Date 2022

Attached Files

File SizeFormat
BB12072.pdf1.03 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.